Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$578M |
| 2 |
Micron Technology
MU
|
+$433M |
| 3 |
Advanced Micro Devices
AMD
|
+$404M |
| 4 |
Amazon
AMZN
|
+$398M |
| 5 |
Accenture
ACN
|
+$358M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$777M |
| 2 |
Meta Platforms (Facebook)
META
|
+$752M |
| 3 |
Tesla
TSLA
|
+$627M |
| 4 |
Chevron
CVX
|
+$528M |
| 5 |
Shopify
SHOP
|
+$439M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.46% |
| 2 | Technology | 18.58% |
| 3 | Consumer Staples | 10.15% |
| 4 | Consumer Discretionary | 9.72% |
| 5 | Financials | 8.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2626
Northeast Community Bancorp
NECB
$372M
| $809K | ﹤0.01% |
65,241
-1,659
| -2% | -$20.7K |
|
2627
Taysha Gene Therapies
TSHA
$1.9B
| $808K | ﹤0.01% |
418,500
-105,100
| -20% | -$382K |
|
2628
VanEck Agribusiness ETF
MOO
$976M
| $807K | ﹤0.01% |
+10,000
| New | +$888K |
|
2629
Q2 Holdings
QTWO
$4.04B
| $805K | ﹤0.01% |
25,000
+9,200
| +58% | +$375K |
|
2630
Aligos Therapeutics
ALGS
$43M
| $804K | ﹤0.01% |
29,224
-6,900
| -19% | -$229K |
|
|
CHCT
2631
Community Healthcare Trust
CHCT
$432M
| $802K | ﹤0.01% |
24,500
-73,400
| -75% | -$2.71M |
|
|
NOAH
2632
Noah Holdings
NOAH
$592M
| $799K | ﹤0.01% |
60,500
-9,400
| -13% | -$160K |
|
2633
Corvus Pharmaceuticals
CRVS
$1.25B
| $798K | ﹤0.01% |
975,519
+12,587
| +1% | +$12K |
|
|
INFI
2634
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
| $798K | ﹤0.01% |
670,612
-90,552
| -12% | -$97.7K |
|
2635
Outset Medical
OM
$84.8M
| $795K | ﹤0.01% |
+3,327
| New | +$891K |
|
2636
Lightpath Technologies
LPTH
$953M
| $794K | ﹤0.01% |
741,700
-70,700
| -9% | -$105K |
|
2637
Vanguard Global ex-US Real Estate ETF
VNQI
$3.51B
| $794K | ﹤0.01% |
20,800
+8,000
| +63% | +$347K |
|
|
PPLI
2638
People Inc
PPLI
$3.01B
| $793K | ﹤0.01% |
+17,465
| New | +$983K |
|
2639
Kopin
KOPN
$1.02B
| $793K | ﹤0.01% |
755,675
-347,764
| -32% | -$486K |
|
2640
Banco Macro
BMA
$4.96B
| $792K | ﹤0.01% |
55,472
+43,472
| +362% | +$587K |
|
2641
Hennessy Advisors
HNNA
$79.3M
| $789K | ﹤0.01% |
90,975
-14,600
| -14% | -$142K |
|
2642
iShares Core 60/40 Balanced Allocation ETF
AOR
$3.75B
| $788K | ﹤0.01% |
17,595
-11,605
| -40% | -$562K |
|
2643
Stoneridge
SRI
$205M
| $788K | ﹤0.01% |
46,519
-14,900
| -24% | -$280K |
|
2644
Scansource
SCSC
$1.08B
| $787K | ﹤0.01% |
+29,810
| New | +$901K |
|
|
TECX
2645
Tectonic Therapeutic
TECX
$682M
| $785K | ﹤0.01% |
101,845
-27,805
| -21% | -$309K |
|
2646
Marten Transport
MRTN
$1.24B
| $784K | ﹤0.01% |
40,900
-254,750
| -86% | -$5.1M |
|
|
CVAC
2647
DELISTED
CureVac
CVAC
| $783K | ﹤0.01% |
+99,348
| New | +$1.16M |
|
|
LOAN
2648
Manhattan Bridge Capital
LOAN
$47.1M
| $781K | ﹤0.01% |
138,428
-37,413
| -21% | -$208K |
|
|
BFX
2649
DELISTED
BowFlex Inc.
BFX
| $781K | ﹤0.01% |
479,100
-673,683
| -58% | -$1.36M |
|
2650
Digi International
DGII
$3.23B
| $778K | ﹤0.01% |
22,500
-25,300
| -53% | -$785K |
|
Similar funds
Jim Simons's Q3 2022 Portfolio in Review
As of Q3 2022, Jim Simons held 4,619 positions worth $70.7B, down 16% from $84.5B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Jim Simons withdrew a net $8.71B in Q3 2022, closing 637 positions and reducing 2,164 holdings. Its most notable exit was Shopify, an estimated $439M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, down from 19% a quarter earlier, followed by Technology and Consumer Staples.
Against the trend, Jim Simons opened a new position in Alphabet (Google) Class A worth $498M.
- Jim Simons's largest Q3 2022 buy was Alphabet (Google) Class A: 5,208,460 shares worth $498M.
- Jim Simons added most to Advanced Micro Devices in Q3 2022, an estimated $404M increase.
- Jim Simons's biggest Q3 2022 reduction was Apple, cutting an estimated $777M.
- Jim Simons fully exited Shopify in Q3 2022, selling an estimated $439M.
- Jim Simons's ten largest holdings make up 11% of its $70.7B portfolio in Q3 2022.
- Jim Simons opened 441 new positions and closed 637 in Q3 2022.
- Jim Simons's portfolio value fell 16% quarter-over-quarter to $70.7B.
Based on Renaissance Technologies's 13F filing for Q3 2022, filed 14 Nov 2022.